Crossmark

Nanoparticle-based drug delivery <i>via</i> RBC-hitchhiking for the inhibition of lung metastases growth

Crossref DOI link: https://doi.org/10.1039/C8NR07730D

Published Online: 2019

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Zelepukin, I. V. https://orcid.org/0000-0003-0209-2116
Yaremenko, A. V. https://orcid.org/0000-0003-0708-5214
Shipunova, V. O. https://orcid.org/0000-0001-6361-1042
Babenyshev, A. V.

Balalaeva, I. V.

Nikitin, P. I. https://orcid.org/0000-0003-1573-5512
Deyev, S. M. https://orcid.org/0000-0002-3952-0631
Nikitin, M. P. https://orcid.org/0000-0002-5682-5891
Funding

Funding for this research was provided by:

Russian Foundation for Basic Research (17-34-50131, 18-29-04065, 17-02-01415, 18-03-01252, 17-00-00121)

Russian Science Foundation (17-74-20146)
License Information

Accepted Manuscript valid from 2019-12-20
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

IDENTIFIERS

: I. V. Zelepukin (ORCID)

: A. V. Yaremenko (ORCID)

: V. O. Shipunova (ORCID)

: P. I. Nikitin (ORCID)

: P. I. Nikitin (ResearcherID)

: S. M. Deyev (ORCID)

: M. P. Nikitin (ORCID)

: M. P. Nikitin (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 22 September 2018; Accepted 12 December 2018; Accepted Manuscript published 20 December 2018; Advance Article published 15 January 2019; Version of Record published 23 January 2019